Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA.
Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA.
J Vasc Surg Venous Lymphat Disord. 2022 Nov;10(6):1352-1358. doi: 10.1016/j.jvsv.2022.06.011. Epub 2022 Aug 5.
Extremity venous aneurysms result in the risk of pulmonary embolism (PE) and chronic venous insufficiency. At present, owing to the rarity of these aneurysms, no consensus for their treatment has been established. The purpose of the present study was to review the presentation, natural history, and contemporary management of extremity venous aneurysms.
We performed a retrospective, multi-institutional review of all patients with extremity venous aneurysms treated from 2008 to 2018. A venous aneurysm was defined as saccular or fusiform with an aneurysm/vein ratio of >1.5.
A total of 66 extremity aneurysms from 11 institutions were analyzed, 40 of which were in a popliteal location, 14 iliofemoral, and 12 in an upper extremity or a jugular location. The median follow-up was 27 months (range, 0-120 months). Of the 40 popliteal venous aneurysms, 8 (20%) had presented with deep vein thrombosis (DVT) or PE, 13 (33%) had presented with pain, and 19 had been discovered incidentally. The mean size of the popliteal venous aneurysms presenting with DVT or PE was larger than that of those presenting without thromboembolism (3.8 cm vs 2.5 cm; P = .003). Saccular aneurysm morphology in the lower extremity was associated with thromboembolism (30% vs 9%; P = .046) and fusiform aneurysm morphology with a thrombus burden >25% (45% vs 3%). Patients presenting with thromboembolism were more likely to have had a thrombus burden >25% in their lower extremity venous aneurysm compared with those who had presented without thromboembolism (70% vs 9%). Approximately half of all the patients underwent immediate intervention, and half were managed with observation or antithrombotic regimen. In the non-operative cohort, three patients subsequently developed a DVT. Eight patients in the medically managed cohort went on to require surgical intervention. Of the 12 upper extremity venous aneurysms, none had presented with DVT or PE, and only 2 (17%) had presented with pain. Of the 66 patients in the entire cohort, 41 underwent surgical intervention. The most common indication was the absolute aneurysm size. Nine patients had undergone surgery because of a DVT or PE, and 11 for pain or extremity swelling. The most common surgery was aneurysmorrhaphy in 21 patients (53%), followed by excision and ligation in 14 patients (35%). Five patients (12%) had undergone interposition bypass grafting. A postoperative hematoma requiring reintervention was the most common complication, occurring in three popliteal vein repairs and one iliofemoral vein repair. None of the patients, treated either surgically or medically, had reported post-thrombotic complications during the follow-up period.
Large lower extremity venous aneurysms and saccular aneurysms with thrombus >25% of the lumen are more likely to present with thromboembolic complications. Surgical intervention for lower extremity venous aneurysms is indicated to reduce the risk of venous thromboembolism (VTE) and the need for continued anticoagulation. Popliteal aneurysms >2.5 cm and all iliofemoral aneurysms should be considered for repair. Upper extremity aneurysms do not have a significant risk of VTE and warrant treatment primarily for symptoms other than VTE.
肢体静脉动脉瘤可导致肺栓塞(PE)和慢性静脉功能不全的风险。目前,由于这些动脉瘤较为罕见,尚未就其治疗达成共识。本研究旨在回顾肢体静脉动脉瘤的表现、自然病史和当代治疗方法。
我们对 2008 年至 2018 年期间治疗的所有肢体静脉动脉瘤患者进行了回顾性、多机构研究。静脉动脉瘤定义为囊状或梭形,动脉瘤/静脉比>1.5。
共分析了 11 个机构的 66 个肢体动脉瘤,其中 40 个位于腘窝,14 个位于髂股,12 个位于上肢或颈静脉。中位随访时间为 27 个月(范围,0-120 个月)。在 40 个腘窝静脉动脉瘤中,8 个(20%)出现深静脉血栓形成(DVT)或 PE,13 个(33%)出现疼痛,19 个为偶然发现。出现 DVT 或 PE 的腘窝静脉动脉瘤的平均直径大于无血栓栓塞的腘窝静脉动脉瘤(3.8cm 与 2.5cm;P=0.003)。下肢囊状动脉瘤形态与血栓栓塞(30%与 9%;P=0.046)相关,梭形动脉瘤形态与血栓负荷>25%(45%与 3%)相关。出现血栓栓塞的患者下肢静脉动脉瘤血栓负荷>25%的可能性高于无血栓栓塞的患者(70%与 9%)。所有患者中约有一半接受了即刻干预,另一半接受了观察或抗血栓治疗。在非手术组中,有 3 例患者随后发生 DVT。有 8 例接受药物治疗的患者随后需要手术干预。在整个队列的 12 例上肢静脉动脉瘤中,均未出现 DVT 或 PE,仅有 2 例(17%)出现疼痛。在整个队列的 66 例患者中,有 41 例接受了手术干预。最常见的指征是绝对动脉瘤大小。9 例患者因 DVT 或 PE 接受手术,11 例患者因疼痛或肢体肿胀接受手术。最常见的手术是动脉瘤修补术,共 21 例(53%),其次是切除术和结扎术,共 14 例(35%)。5 例(12%)患者接受了间置旁路移植术。术后血肿需要再次干预是最常见的并发症,发生在 3 例腘窝静脉修复术和 1 例髂股静脉修复术。在随访期间,无论是手术治疗还是药物治疗的患者均未报告出现血栓后并发症。
下肢大静脉动脉瘤和血栓负荷>25%管腔的囊状动脉瘤更易发生血栓栓塞并发症。下肢静脉动脉瘤手术干预可降低静脉血栓栓塞(VTE)风险和持续抗凝的需要。>2.5cm 的腘窝动脉瘤和所有髂股动脉瘤均应考虑修复。上肢动脉瘤发生 VTE 的风险不高,主要需要治疗 VTE 以外的症状。